US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Benitec Biopharma Inc. - Common Stock (NQ:BNTC)

8.980 -0.600 (-6.26%)
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Benitec Biopharma Inc. - Common Stock

News headline image
Benitec Biopharma Inc. Announces Closing of $30 Million Underwritten Public Offering
From Benitec Biopharma Inc.
Via GlobeNewswire
Benitec Biopharma Inc. (NASDAQ: BNTC) Near the Top of Equities by Percentage Gain on 8/9
Via Investor Brand Network
News headline image
Benitec’s (NASDAQ: BNTC) IND for BB-301 Cleared by FDA: A Milestone for OPMD Treatment
Benitec Biopharma Inc. (NASDAQ: BNTC), a leader in gene therapy, has announced that the U.S. Food and Drug Administration (FDA) 
Via Spotlight Growth